Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Follow-up of erlotinib related uveitis
View through CrossRef
The authors report the follow-up of a 68-year-old lady with bilateral anterior uveitis secondary to erlotinib. Erlotinib was started and stopped after symptoms and signs suggestive of severe bilateral anterior uveitis were noted. The patient developed signs of a non-ST elevation myocardial infarction, 12 days after stopping the erlotinib, and recovered without major problems. The patient also reported intermittent low-grade fever since starting erlotinib which resolved after stopping this drug. No further symptoms of uveitis were noted up to 6 month follow-up. The patient reported improved well being, resolution of ocular symptoms and intermittent low-grade fever at last follow-up (6 months after stopping erlotinib).
Title: Follow-up of erlotinib related uveitis
Description:
The authors report the follow-up of a 68-year-old lady with bilateral anterior uveitis secondary to erlotinib.
Erlotinib was started and stopped after symptoms and signs suggestive of severe bilateral anterior uveitis were noted.
The patient developed signs of a non-ST elevation myocardial infarction, 12 days after stopping the erlotinib, and recovered without major problems.
The patient also reported intermittent low-grade fever since starting erlotinib which resolved after stopping this drug.
No further symptoms of uveitis were noted up to 6 month follow-up.
The patient reported improved well being, resolution of ocular symptoms and intermittent low-grade fever at last follow-up (6 months after stopping erlotinib).
Related Results
Uveitis in Adults
Uveitis in Adults
ImportanceUveitis is characterized by inflammation of the uvea—the middle portion of the eye composed of the iris, ciliary body, and choroid—causing eye redness, pain, photophobia,...
Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)
Mechanisms of Enhanced Radiation Response following Epidermal Growth Factor Receptor Signaling Inhibition by Erlotinib (Tarceva)
Abstract
Erlotinib (Tarceva) is an orally available HER1 (epidermal growth factor receptor, EGFR) tyrosine kinase inhibitor advancing through clinical trials for the...
Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period
Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period
Objectives: The aim of this study was to establish the etiology of uveitis and to examine its relationship with anatomical localization, age, and gender. Methods: A prospective stu...
Association between uveitis onset and economic development in mainland China
Association between uveitis onset and economic development in mainland China
Abstract
Background
Economic prosperity has fostered numerous changes that may translate into better or worse outcomes across all domains of health. This study aims to exp...
Pattern of uveitis in tertiary care hospital in Tripura, India
Pattern of uveitis in tertiary care hospital in Tripura, India
Introduction:
Uveitis is characterized by inflammation of uveal tissue which can lead to significant loss of vision if not treated promptly. The uveitis pattern differs...
PREVALENCE AND COMPARISON OF UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH POSITIVE AND NEGATIVE ANTI-NUCLEAR ANTIBODIES AT A TERTIARY CARE HOSPITAL
PREVALENCE AND COMPARISON OF UVEITIS IN JUVENILE IDIOPATHIC ARTHRITIS PATIENTS WITH POSITIVE AND NEGATIVE ANTI-NUCLEAR ANTIBODIES AT A TERTIARY CARE HOSPITAL
Background: Juvenile Idiopathic Arthritis (JIA) is the most common pediatrics rheumatic disease, with uveitis as a masquerading and severe extra-articular manifestation causing maj...
Pattern of Uveitis at a Tertiary Eye Care and Training Center, North-West Ethiopia
Pattern of Uveitis at a Tertiary Eye Care and Training Center, North-West Ethiopia
Abstract
Objective: Uveitis can potentially cause irreversible ocular damage and blindness and knowing its characteristic clinical features is essential in making an accura...
Erlotinib-related bilateral anterior uveitis: Figure 1
Erlotinib-related bilateral anterior uveitis: Figure 1
The authors report the case of a 68-year-old woman with secondary adenocarcinoma of the lungs from an unknown primary. Erlotinib was started which produced symptoms suggestive of u...